ARTICLE | Financial News
McMaster cancer spinout launches with $25M
February 23, 2017 11:21 PM UTC
Radiotherapeutics company Fusion Pharmaceuticals Inc. (Hamilton, Ontario) launched with a $25 million series A round led by existing investor Johnson & Johnson Innovation-JJDC Inc. New investors HealthCap, TPG Biotech and Genesys Capital also participated along with existing investor FACIT.
The company spun out of the Centre for Probe Development and Commercialization at McMaster University (Hamilton, Ontario)...